Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;114(3):339-44.
doi: 10.1007/s11060-013-1189-0. Epub 2013 Jun 29.

Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma

Affiliations

Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma

Sadhana Jackson et al. J Neurooncol. 2013 Sep.

Abstract

Diffuse intrinsic pontine glioma (DIPG) is the deadliest central nervous system tumor in children. The survival of affected children has remained poor despite treatment with radiation therapy (RT) with or without chemotherapy. We reviewed the medical records of all surviving patients with DIPG treated at our institution between October 1, 1992 and May 31, 2011. Blinded central radiologic review of the magnetic resonance imaging at diagnosis of all surviving patients and 15 controls with DIPG was performed. All surviving patients underwent neurocognitive assessment during follow-up. Five (2.6 %) of 191 patients treated during the study period were surviving at a median of 9.3 years from their diagnosis (range 5.3-13.2 years). Two patients were younger than 3 years, one lacked signs of pontine cranial nerve involvement, and three had longer duration of symptoms at diagnosis. One patient had a radiologically atypical tumor and one had a tumor originating in the medulla. All five patients received RT. Chemotherapy was variable among these patients. Neurocognitive assessments were obtained after a median interval of 7.1 years. Three of four patients who underwent a detailed evaluation showed cognitive function in the borderline or mental retardation range. Two patients experienced disease progression at 8.8 and 13 years after diagnosis. A minority of children with DIPG experienced long-term survival with currently available therapies. These patients remained at high risk for tumor progression even after long follow-ups. Four of our long-term survivors had clinical and radiologic characteristics at diagnosis associated with improved outcome.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Fig. 1a T2-weighted axial brain MRI of patient 2 at diagnosis Fig. 1b T2-weighted axial brain MRI of patient 2 obtained 12.2 years after her diagnosis and before tumor progression
Figure 1
Figure 1
Fig. 1a T2-weighted axial brain MRI of patient 2 at diagnosis Fig. 1b T2-weighted axial brain MRI of patient 2 obtained 12.2 years after her diagnosis and before tumor progression
Fig. 2
Fig. 2
Intelligence scores of surviving patients Of note, patient 1 only underwent testing by Wechsler intelligence scale for children, 4th edition (WISC-IV) because of significant dysarthria Abbreviations: FSIQ, full scale intellectual quotient; VCI, verbal comprehension index; PRI, perceptual reasoning index; WMI, working memory index; PSI, processing speed index

References

    1. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7:241–248. - PubMed
    1. Puget S, Philippe C, Bax DA, et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One. 2012;7:e30313. - PMC - PubMed
    1. Monje M, Mitra SS, Freret ME, et al. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A. 2011;108:4453–4458. - PMC - PubMed
    1. Broniscer A, Leite CC, Lanchote VL, Machado TM, Cristófani LM. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol. 2000;18:1246–1253. - PubMed
    1. Greenberg ML, Fisher PG, Freeman C, et al. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatr Blood Cancer. 2005;45:644–648. - PubMed

Publication types

LinkOut - more resources